Hair loss research and results - Thymuskin
Order Thymuskin | More on Thymuskin | Hair Growth kits

Nine physicians - professors at the universities who were oncologists, dermatologists, gynecologists and general internists - participated in the production of a thymus gland extract called ThymuSkin, a product they developed primarily for cancer patients who were subjected to chemotherapy.

The preceding progression shows a female with alopecia areata. Before treatment with ThymuSkin, after several weeks of treatment, after several months of treatment with ThymuSkin, then finally after a year and a half.

These physicians performed placebo controlled, double-blind studies on the effects of this product on hair loss in cancer patients. When the product was rubbed on the patient's scalp before he/she took a chemotherapeutic agent, there was no hair fallout -- hair loss was kept at a minimum.. The German GMP subsequently declared the product to be a preventative for hair fallout for chemotherapy patients.

However, it was soon discovered by the research physicians that ThymuSkin was very effective against rare types of hair loss and scalp disorders. So it was declared a treatment for the regrowth of hair. It has been proven to be effective for men 67% of the time, and for women 95% of the time who still have live hair follicles.

Complete remission in a 40 year old patient with alopecia areata totalis after 18 months local treatment with ThymuSkin.

The pictures above are typical in nature and taken from the Double Blind Placebo Controlled Studies involving over 3000 participants, conducted in eight leading hospitals and university clinics throughout Europe:
Vienna City Hospital - Austria Dept.of Surgery, Municipal Clinics of Darmstadt - University of Frankfurt, Ruprecht - Karls University of Heidelberg - Gynecological Clinic, University Clinic of Meunster - Oncology / Surgery, Medical Clinic of the University of Munich - Dept of Hematology/Oncology, Division of Pharmacology and Toxicology - University of Osnabrueck, The Medical University of Hanover and the German Cancer Research Center, Heidelberg.

Partial remission of a 37 year old patient with alopecia areata universalis for 14 years before treatment, after 9 months local treatment with THYMUSKIN

Therapeutic Successes Against Both Types of Alopecia

Dr. med. Moessler’s results from her participating with Prof. Dr. med. Hagedorn in their third hair preservation and regrowth investigation were remarkable for changing the appearance of balding people. In her paper, she states:

Fifty-one patients with Alopecia androgenetica and sixteen patients with Alopecia areata were treated with Thymu-Skin® (shampoo and tonic containing a thymus extract) over a period of twelve months. Sixty-seven percent of the male patients with androgenetic alopecia had a benefit from this treatment. In 83 percent of the patients with Alopecia areata, Thymu-Skin® therapy resulted in partial or full regrowth of scalp hair. In female patients with Alopecia androgenetica the average daily hair loss (of individual hair strands) decreased from 139 (pretreatment) to 57 after twelve months. There was no remarkable change in male patients. In patients with Alopecia Areata the average hair loss (individual hair strands) decreased from initially 245 to 10.

The two specific Thymu-Skin® products, hair shampoo and hair tonic manufactured by Thymu-Skin Cosmetic Klett-Loch GmbH of Manheim, Germany, were utilized to acquire such marvelous results in Dr. Moessler’s study. The gel, hair mask, and conditioner crème rinse were not used because they did not exist then. The therapeutic successes against both types of alopecia were analyzed in relation to the duration of hair loss for individual patients—both men and women. A scoring system was developed using the following classification: “Improvement” was +1, “no change” was 0 and “progression” (of hair loss) was –1. The duration of hair loss was classified in intervals of 1 to 12 months, 13 to 30 months, 31 to 60 months, and more than 60 months.

Telling the story of success or failure for hair preservation are the detailed results of Thymu-Skin® usage shown below. They are divided into subjective improvement in relation to the duration of hair loss and objective therapeutic success evaluated by hair strand counts.

Subjective Improvement Relating to Duration of Hair Loss Among Men from Androgenetic Alopecia (Male Pattern Baldness)

· For men with male pattern baldness (MPB) present for from 1 to 12 months, 20 percent observed improvement (+1), 20 percent had no change (0), and 60 percent observed hair loss progress (-1);

· For men with MPB present for from 13-30 months, 50 percent (improvement (+1), 25 percent experienced no change (0), and 25 percent observed hair loss progression (-1);

· For men with MPB present for from 31 to 60 months, 25 percent had improvement (+1), 75 percent saw no change (0), none progressed to further hair loss(-1).

Objective Hair Strand Counts for Hair Preservation in Male Pattern Baldness

For men with MPB, the average number of daily hair strands lost by the male participants in this study was 119 before treatment, 98 after three months of treatment and only 76 after six months (less than the usual fallout of 80 strands per day).

Thymu-Skin® Results for Female Pattern Baldness Are Superior

For women with androgenetic alopecia the effects of using topically applied calf thymus extract containing nutrients were even better. As stated in her summary, Dr. Moesler said that 100 percent of her female patients benefited. Accordingly, she added an extra classification that described the impressions held by women in this study of Thymu-Skin® for the treatment of female pattern baldness (FPB).

Women’s Subjective Impressions About Thymu-Skin® Usage for FPB

·  For women with FPB, 49 percent had the impression that new hair growth was present after three months. They observed improvement (+);

· For women with FPB, 51 percent saw no change (0) in three months of product usage;

· For women with FPB, 72 percent experienced good new hair growth-improvement (+1)—after six months of usage;

·  For women with FPB, 21 percent saw no change (0) in six months;

·  For women with FPB, 7 percent observed a progression of hair loss after six months of product use;

·  For women with FPB, 19 percent observed no change (0) after nine months;

·  For women with FPB, 14 percent felt that hair loss progression (-1) had occurred.

At the conclusion of this study, all of the participating women stated their personal satisfaction with therapeutic success they experienced in treating androgenetic alopecia. Their hair loss either stopped or they saw new hair growth with which they were highly pleased.

Subjective Improvement Relating to Duration of Hair Loss Among Women from Androgenetic Alopecia (Female Pattern Baldness)

·  For women with female pattern baldness (FPB) present for from 1 to 12 months, 83 percent observed improvement (+1), 17 percent had no change (0), and none of the women observed further hair loss progression (-1);

·  For women with (FPB) present for from 13 to 30 months, 78 percent had improvement (+1), 22 percent experienced no change (0), and none observed any progression (-1) to further hair loss;

·  For women with FPB present for from 31-60 months, 60 percent had improvement (+1), 22 percent saw no change (0), and, surprisingly, 18 percent reported they had progressed to further hair loss (-1).

Objective Hair Strand Counts for Hair Preservation in Female Pattern Baldness

For women with FPB, the average number of daily hair strands lost by the female participants in this study was 139 before treatment with the calf thymus extract, 90 after three months of treatment, 80 after six months, and 57 after twelve months (less than the usual female hair fallout).

Subjective Improvement Relating to Duration of Hair Loss from Alopecia Areata (AA) Among Both Sexes

·  For study participants having AA present for from 1 to 12 months, 40 percent observed improvement (+1), 40 percent had no change (0), and 20 percent observed hair loss progression (-1);

·  For subjects with AA present for from 13 to 30 months, 50 percent had improvement (+1), 40 percent saw no change (0), and none progressed to further loss (-1).

For all patients with a duration of hair loss of more than 60 months, new hair growth was observed where there had been bare scalp patches before.

Objective Hair Strand Counts for Hair Preservation in Alopecia Areata

For men and women having AA, the average number of daily hair strands lost by the participation in this study was 245 before treatment with the shampoo and tonic of Thymu-Skin®, 195 after three months of treatment, 164 after six months, 80 after nine months, and only 10 after twelve months.

During the total period of treatment, Thymu-Skin® showed no local or systemic adverse side effects, except that T-lymphocyte counts improved somewhat, which was a positive immune system response.

Subjective Impressions About Thymu-Skin® Usage for Alopecia Areata (AA)

·  For men and women participants in this study who had AA, 31 percent had the impression that new hair growth was present after three months. They observed improvement (+1);

·  44 percent saw no change (0) in three months of product usage;

·  25 percent observed progression toward more hair loss;

·  47 percent experienced good new hair growth—an improvement (+1)—after six months of usage;

·  33 percent saw no change (0) in six months;

·  20 percent observed a progression of hair loss after six months of product use;

·  75 percent observed much improvement (+1) after nine months of self-administering Thymu-Skinâ;

·  17 percent observed no change (0) after nine months;

·  8 percent felt that hair loss progression (-1) had occurred;

· After twelve months of local therapy with Thymu-Skin® there was no progression toward further hair loss, but rather improvement in 86 percent of patients with alopecia areata. In 14 percent the status of their hair growth did not change.